Navigation Links
The Feinstein to collaborate with Sweden's Karolinska Institute
Date:4/9/2008

MANHASSET, NY As part of its global mission of advancing science, The Feinstein Institute for Medical Research announced today that it has signed a collaborative agreement with the renowned Karolinska Institutet in Sweden. The agreement paves the way for Karolinska graduates to conduct post-doctoral research in New York and scientists from The Feinstein to study at the Karolinskas laboratories in Stockholm.

The Karolinska Institutet is always looking for outstanding training environments for their graduates, said Kevin J. Tracey, MD, director and chief executive of The Feinstein. And we want the students of our Elmezzi Graduate School of Molecular Medicine to have a challenging post-doctoral career as well. It couldnt be a better fit.

According to the agreement, both institutes have established joint programs to enhance the training and research of each institutes students and post-doctoral researchers. The collaboration will mean that as many as half a dozen scientists may be able to study abroad and that Feinstein scientists can host an equal number of Karolinskas post-doctoral students. They will still have to apply for a seat in the lab in New York or abroad, and a joint admissions committee from both institutes will review the applications and make the selections.

Our mission is translational research, and we offer a progressive basic and clinical training environment, added Dr. Tracey, an immunologist who collaborated with Karolinskas Jan Andersson, M.D., the head of infectious diseases, studying cytokines and inflammation. Dr. Andersson was also the first invited lecturer for The Feinstein Institutes Marsh lecture in 2005. His research includes the study of the potential role of regulatory T-cells in HIV/AIDS. He has discovered that HIV infection is associated with an increase of regulatory T-cells that negatively affect the capacity to mount a fully functional CD8 T-cell response against the infection. These regulatory T-cells could become a target for future treatments to reconstitute the immune system damaged by HIV infection.

The graduate students at the Karolinska and The Feinstein are medical doctors who have gone on to obtain a doctoral degree in research. The faculty leadership is always looking for the best and brightest post-doctoral students, said Dr. Tracey. These students are the heart of the lab.


'/>"/>

Contact: Jamie Talan
jtalan@nshs.edu
516-562-1232
North Shore-Long Island Jewish (LIJ) Health System
Source:Eurekalert

Related medicine news :

1. Sens. Kerry, Boxer and Feinstein call on FDA to Establish Maximum Level for Lead in Lipstick
2. The Wistar Institute collaborates with the Coriell Institute to distribute cell lines
3. INCF and Allen Institute for Brain Science collaborate on Brain Atlas service improvement
4. AMA Foundation and ReachMD Collaborate to Broadcast Excellence in Medicine Awards
5. The National ePrescribing Patient Safety Initiative Collaborates With Google
6. Quest Diagnostics to Collaborate with Google on New Health Offering
7. Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle
8. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
9. Cleveland Clinic Collaborates with Google
10. BayCare Health System Collaborates With Accenx to Provide Reliable Exchange of Information
11. Geisinger and Celera to collaborate on liver disease test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... Source Vitál Apothecary, a skin and body care company dedicated to creating ... a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition Conference in ... nutritional, sports and health industries a chance to meet in private sessions with some ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, ... everyday lives, recently attended the January ECRM Trade Show in Hilton Head, SC, ... for its large range of supplements that keep the body functioning at its ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... and its sugar-free alternative VW+ 002. The drinks have been produced in collaboration ... conditions to perform during your workout. , After a successful launch in Sweden ...
(Date:1/20/2017)... ... ... You”: a fine examination of how God handles sin, including how to let go ... Miller, who, for over ten long years has been waiting to release this powerful insight ... he has been serving the Lord for over twenty years, and he has been preaching ...
(Date:1/20/2017)... ... ... “Knowledge is God’s Lighthouse”: a moving and colorful collection of prayers that ... of published author, Gene Gaapf, a retired truck driver, and a long-time writer, whose ... since high school and have many different titles,” Gaapf mentions about his different works. ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017  Today, during ... Conference, "PI3K Pathways in Immunology, Growth Disorders ... (NASDAQ: INFI ) presented preclinical ... candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical ... help overcome resistance to checkpoint inhibition by ...
(Date:1/20/2017)... Jan 20, 2017 Research and Markets ... Market (by Devices, Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales ... their offering. ... Global Hearing Aids Market Sales Volume, Company Analysis and ... high-growth hearing aid industry. The growing prevalence of ...
(Date:1/20/2017)...  Palladian Health, a leading provider of quality ... an opioid management program which assists physicians in ... stem the growing tide of dependence on prescription ... non-cancer pain (back pain, neck pain, and degenerative ... evidence regarding long-term effectiveness. The new ...
Breaking Medicine Technology: